Journal
EUROPEAN JOURNAL OF CANCER
Volume 46, Issue 8, Pages 1365-1373Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.ejca.2010.02.031
Keywords
Endometrial cancer; MSI; PTEN; Prognostic factor
Categories
Funding
- National Cancer Institute of Canada
- Womens Health Foundation
- BRAS family Drug Development Program
Ask authors/readers for more resources
Aim: The impact of PTEN status and microsatellite instability (MSI) on the prognosis of women with endometrial cancer is controversial. The aim of this study was to investigate MSI and PTEN expression in two patient populations using data from NCIC CTG studies. Methods: Archival paraffin embedded tumour from women with endometrial cancer enrolled in NCIC CTG studies: ENS (stage I/II) and IND 126, 148 and 160 (advanced/recurrent disease) were examined for MSI using BAT25/26 and for PTEN expression using immunohistochemistry. PTEN and MSI status were correlated with clinicopathologic variables and survival using data from NCIC CTG trial databases. Results: PTEN and MSI results were available from 128 and 163 patients, respectively. MSI+ tumours were more common in women enrolled in ENS compared to the IND studies (p = 0.01). PTEN negative tumours were associated with improved survival in both univariate (hazard ratio (HR) 0.55, 95% confidence interval (CI) 0.32-0.94; p = 0.03) and multivariate (adjusted HR 0.54, 95% CI 0.30-0.96; p = 0.03) analyses in women enrolled in IND studies. Microsatellite stable tumours were associated with an improved prognosis in univariate (HR 0.18, 95% CI 0.06-0.51; p < 0.0001) and multivariate (adjusted HR 0.16, 95% CI 0.05-0.5; p < 0.0001) analyses in women enrolled in ENS. There was no significant correlation between MSI and PTEN status. Conclusions: PTEN negative tumours in women with advanced disease are associated with improved survival. MSI+ tumours are more common in early stage disease and in this group of women are associated with a worse prognosis. (C) 2010 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available